0001209191-18-041385.txt : 20180703 0001209191-18-041385.hdr.sgml : 20180703 20180703210322 ACCESSION NUMBER: 0001209191-18-041385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180702 FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOFFMAN ROBERT CENTRAL INDEX KEY: 0001166288 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33221 FILM NUMBER: 18939323 MAIL ADDRESS: STREET 1: ARENA PHARMACEUTICALS INC STREET 2: 6166 NANCY RIDER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/ CENTRAL INDEX KEY: 0000818033 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942875566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6503662626 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AP PHARMA INC /DE/ DATE OF NAME CHANGE: 20010511 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-02 0 0000818033 HERON THERAPEUTICS, INC. /DE/ HRTX 0001166288 HOFFMAN ROBERT 4242 CAMPUS POINT COURT SUITE 200 SAN DIEGO CA 92121 0 1 0 0 CFO & SVP, Finance Common Stock 2018-04-30 5 J 0 E 744 13.2175 A 1280 D Common Stock 2018-07-02 4 M 0 30000 15.30 A 31280 D Common Stock 2018-07-02 4 S 0 28940 38.1516 D 2340 D Common Stock 2018-07-02 4 S 0 1060 38.7953 D 1280 D Employee Stock Option (Right to Buy) 15.30 2018-07-02 4 M 0 30000 0.00 D 2027-04-24 Common Stock 30000 100000 D Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2018. The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 30, 2018. The range of sales prices received was $37.60 to $38.60. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. The range of sales prices received was $38.625 to $38.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Options vest and become exercisable with respect to 32,500 shares on the first anniversary of his first day of employment (the "Grant Date"), followed by 97,500 shares vesting ratably each month over the subsequent three years, such that 130,000 options will be fully vested on the four year anniversary of the Grant Date. /s/ Robert E. Hoffman 2018-07-03